ZY
Zhengye Biotechnology Holding Limited
ZYBT · NASDAQ
$1.37 -2.84% (-$0.04)
1M -29.74%
Market Cap ¥434.2M
P/E Ratio -
Div. Yield -
ROE 25.78%
Valuation
32 /100
Expensive P/FCF 617.70x
P/S 3.73x
P/B 1.74x
Growth
0 /100
Declining Book val. growth 5.55%
Rev. growth 23.53%
FCF growth N/A
Profitability
9 /100
Weak Op. margin 58.66%
Gross margin 20.51%
FCF margin 0.60%
Quality
3 /100
Poor ROA 15.99%
ROIC 20.63%
Asset turnover 0.27x
Debt
57 /100
Moderate Int. coverage -20.14x
Debt/Equity 0.30x
Current ratio 1.14x
Stability
55 /100
Moderate EPS volatility 33.86%
Beta -2.53x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ZYBT
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Songlin Song
Employees
269
Headquarters
Jilin